TECXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Tectonic Therapeutic, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$21.15+0.50 (+2.42%)
Close on Oct 19, 2026
- Market cap
- $401.09M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Tectonic Therapeutic statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Tectonic Therapeutic | Industry median |
|---|---|---|
| Market Cap | $413.47M | $166.30M |
| Enterprise Value | $186.40M | $88.19M |
| PB Ratio | 1.85 | 2.03 |
| P/TBV Ratio | 1.85 | 2.29 |
Income (trailing twelve months)
| Measure | Tectonic Therapeutic | Industry median |
|---|---|---|
| Operating Income | -$94.93M | -$21.40M |
| Net Income | -$85.79M | -$22.46M |
| EBITDA | -$93.66M | -$16.91M |
| EPS (Diluted) | -$4.57 | -$0.83 |
Returns
| Measure | Tectonic Therapeutic | Industry median |
|---|---|---|
| Return on Equity (ROE) | -33.8% | -53.2% |
| Return on Assets (ROA) | -32.2% | -40.9% |
| Return on Capital Employed (ROCE) | -41.9% | -38.1% |
Balance sheet
| Measure | Tectonic Therapeutic | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $227.07M | $61.43M |
| Net Cash (Debt) | $227.07M | $15.35M |
| Net Cash Per Share | $11.62 | $0.66 |
| Equity (Book Value) | $223.85M | $49.09M |
| Book Value Per Share | $11.45 | $1.37 |
| Tangible Book Value | $223.85M | $23.52M |
| Working Capital | $220.73M | $76.81M |
Financial position
| Measure | Tectonic Therapeutic | Industry median |
|---|---|---|
| Current Ratio | 22.29 | 3.34 |
| Quick Ratio | 21.90 | 2.44 |
| Interest Coverage | -2373.13 | -6.26 |
Cash flow (trailing twelve months)
| Measure | Tectonic Therapeutic | Industry median |
|---|---|---|
| Operating Cash Flow | -$72.14M | -$12.35M |
| Capital Expenditures | -$279.00K | -$1.08M |
| Free Cash Flow | -$72.42M | -$20.22M |
| FCF Per Share | -$3.70 | -$0.42 |
Efficiency
| Measure | Tectonic Therapeutic | Industry median |
|---|---|---|
| Profits Per Employee | -$1.43M | -$703.34K |
| Employee Count | 60 | 74 |
Dividends and yields
| Measure | Tectonic Therapeutic | Industry median |
|---|---|---|
| Earnings Yield | -20.7% | -23.3% |
| FCF Yield | -17.5% | -8.72% |
| Dividend Yield | 0.00% | 1.82% |
| Shareholder Yield | 0.00% | 0.00% |
| Dividend Per Share | $0.00 | $0.83 |
| Years of Dividend Growth | 0 | 0 |
Shares
| Measure | Tectonic Therapeutic | Industry median |
|---|---|---|
| Shares Outstanding | 19,549,400 | 58,127,000 |
| Shares Change (YoY) | 14.9% | 10.9% |
| Shares Change (QoQ) | 2.15% | 0.54% |
| Float | 11,129,000 | 49,136,700 |
| Shares Held by Insiders | 43.1% | 11.6% |
| Shares Held by Institutions | 71.4% | 59.4% |
Scores
| Measure | Tectonic Therapeutic | Industry median |
|---|---|---|
| Altman Z-Score | 17.01 | -0.22 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Tectonic Therapeutic's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.